NCT00944216View on ClinicalTrials.gov

Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study

PHASE4TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Keratosis Pilaris
Interventions
DRUG

Salkera Emollient Foam

application of the Salkera emollient foam twice a day during the 12 week study period.

Trial Locations (1)

45408

Wright State University School of Medicine, Department of Dermatology, Dayton

Sponsors
All Listed Sponsors
collaborator

PreCision Dermatology, Inc.

INDUSTRY

lead

Wright State University

OTHER

NCT00944216 - Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study | Biotech Hunter | Biotech Hunter